Abstract-Adenosine produced a slight but concentration-dependent relaxation in rabbit aortic strips preconstricted with norepinephrine. The effect of adenosine was markedly augmented in the presence of hydralazine.
Abstract-Adenosine produced a slight but concentration-dependent relaxation in rabbit aortic strips preconstricted with norepinephrine. The effect of adenosine was markedly augmented in the presence of hydralazine.
On the other hand, the adenosine-induced relaxation was attenuated by 8-phenyltheophylline, but was unaffected by indomethacin, nordihydroguaiaretic acid and quinacrine, indicating that adenosine acts via purinergic receptors and that vasodilating metabolites of arachidonic acid are not involved in the relaxation.
The adenosine-induced relax ation remained unaffected by S-(p-nitrobenzyl)-6-thioguanosine (NBTG) or 2'-deoxycoformycin (2'DCF), alone or combined. NBTG significantly inhibited the incorporation of [3H] adenosine, while the content of [3H] compound was increased by 2'DCF, but was unchanged by hydralazine. Hydralazine also augmented the 2-chloroadenosine-induced relaxation. These results suggest that the augmen tation of adenosine-induced relaxation with hydralazine does not result from an inhibition of adenosine transport and/or adenosine deaminase.
When adenosine was added, relaxation was elicited with concomitant increase in cAMP, but with no significant change in cGMP.
In the presence of hydralazine, the cAMP increasing effect of adenosine was augmented, and the level of cGMP increased with adeno sine. These changes in cyclic nucleotide levels might at least in part explain the augmentation of adenosine-induced relaxation with hydralazine.
Hydralazine is assumed to exert its blood pressure lowering effect by a direct action on arteriolar smooth muscle cells (1) . However, indirect mechanisms have also been dis cussed: for example, the induction of a release of the vasodilator prostaglandin E2 and 12 (2) or an interference with sympathetic transmitter release at the level of the vascular smooth muscle (3) . Recently, Spokas et al. (4) have presented convincing evidence that the endothelial component of the hydralazine response represents a major contribution to the net relaxant effect on vascular smooth muscle, particularly at low concentrations that are of clinical relevance. On the other hand, several different mechanisms for the intracellular action of hydralazine have been suggested by many workers (5) (6) (7) (8) . However, the mechanism responsible for the anti hypertensive action of hydralazine has been the subject of considerable controversy and remains to be clarified.
We have recently found that the adenosine induced relaxation in rabbit aortic strips pre constricted with norepinephrine is markedly augmented in the presence of hydralazine at concentrations which do not exert any relaxa tion activity. Adenosine is considered to be an important regulator of blood flow in a variety of organs. This function of adenosine is based on its relaxant effect on arteries. The present experiments were, therefore, under taken to investigate the mechanism of the augmentation in connection to the mecha nism responsible for the antihypertensive action of hydralazine. ) . Indomethacin (Merck) and NBTG were dissolved in dimethylsufoxide (DMSO, Art. 2950), which was present in a final con centration of 0.5% v/v or less in all exper iments with these agents, and this concen tration had no effect on any parameters studied.
Materials and Methods

Chemicals
Measurements of the mechanical re sponses of aortic strips: Measurements of the mechanical responses of aortic strips were performed as described in the previous report (9) . Briefly, male albino rabbits weighing about 2.5 kg were sacrificed by exsanguination and the thoracic aorta was rapidly excised. After removal of the ad ventitial connective tissue, helical strips 3 mm wide and 25 mm long were prepared. These preparations were denuded of a functional endothelium (10) to avoid any complicating effects of endothelium and mounted vertically in a 20 ml jacketed organ bath filled with modified Krebs' solution at 37'C and gassed with 95% 02 and 5% C02. The composition of the modified Krebs' solution was as follows: 115.0 mM NaCl, 4.7 mM KCI, 1.2 mM MgS02' 7H20,2.5 mM CaC12.2H20, 1.2 mM KH2P04, 25.0 mM NaHC03 and 10.0 mM glucose. One end of each strip was attached to the lower end of a stainless rod which was mounted independently from the organ bath. The other end was attached to a force-displace ment transducer (SB-1T, Nihon Kohden Kogyo Co., Tokyo). Isometric changes in tension were recorded on a pen-writing oscillograph (Wi-681 G, Nihon Kohden Kogyo Co.). Lengh of the strips was ad justed several times until a stable tension of 2 g was attained. Before beginning the ex periments, strips were allowed to equilibrate for at least 60 min in the bathing solution and during this period, the bathing solution was replaced every 20 min with fresh solution.
To compare the relaxation activity, strips were exposed to 10-6 M NE for 10 min in the presence of 3 x 10-6 M cocaine and 5.7 x 10-4 M ascorbic acid. During this period, the strips had attained a steady state level of tone. Then, adenosine or 2-chloroadenosine in a single concentration was added to the bathing solution. Cumulative dose-response curves for adenosine were obtained by a stepwise increase in the concentration as soon as a steady response was attained with the preceding concentration.
The dose response curves for adenosine were obtained prior to and following hydralazine at different concentrations in the same tissue. After studying the effects of the first concentration of hydralazine, the tissue was washed out until the second control response was recorded.
Relative relaxation value was calculated by taking the percentage relaxation with relax ation agonists against 10-6 M NE-induced contraction in the absence of test agents as a value of 1.0. Unless otherwise stated, agents to be tested were added 10 min prior to NE (i.e., 20 min prior to relaxation agonists). It has been determined by the preliminary ex periments that this incubation time is suf ficient to augment the adenosine-induced relaxation; that is, the magnitude of augmen tation was not significantly different when hydralazine was added 10, 20 or 50 min prior to N E.
Uptake studies: Uptake studies were car ried out by the following method: Aortic spiral strips prepared as described above were weighed and preincubated at 37°C for 5 min in 5 ml modified Krebs' solution gassed with 95%02 and 5% C02. The time schedule for the treatment with agents was the same as that for determination of the mechanical responses:
after 10 min-incubation with agent or vehicles, the preparations were treated with 10-6 M NE for 10 Measurements of cyclic nucleotide levels: For measurements of cyclic nucleotide levels, aortic strips were suspended as described pre viously in an organ bath under 2 g load and allowed to equilibrate for at least 60 min. At any time in experiments, the organ bath could be instantly dropped down, leaving the supporting preparation accessible for im mediate freezing in liquid N2. After 10 min exposure to 10-6 M NE, each strip was treated with 10-4 M adenosine for 2 min and then frozen in liquid N2. Frozen tissues were homogenized in ice-cold 6% trichloroacetic acid, and extracts were assayed for cyclic AMP and cyclic G M P by a sensitive radioim munoassay procedure (1 1) using commer cially available kits (Yamasa Shoyu Co., Japan). All assays were performed in dupli cate. To test the effect of hydralazine, it was added 10 min prior to NE (i.e., 20 min prior to adenosine).
Statistical analyses: Results in the text, Table and Figures are expressed as the mean±S.E. For statistical evalution, data were analyzed by Student's t-test. Hydralazine at a concentration of 10-5 M or less, per se, did not produce relaxation in the preconstricted aorta. However, relaxation of the strips to 3x10-5, 10-4 and 3x10-4 M of the antihypertensive agent was determined as 5.6±1.6, 21.9±3.4 and 40.9±2.0% (n=9), respectively, against 10-6 M NE-induced contraction (4. 19±0.21 g, n=9) .
Effects of some agents on the adenosine induced relaxation: Adenosine (10-4 M) induced relaxation in the preconstricted aortic strips was markedly augmented by 3x10-6 M hydralazine, while it was at tenuated (68.0±5.1%, n=6) in the presence of 10-5 M 8PT, a potent adenosine receptor antagonist (12) . In addition, the augmented relaxation in the presence of 3 x 10-6 M hy dralazine was clearly attenuated (48.6+5.4%, n=6) by 10-5 M 8PT. However, neither indomethacin (10-5 M), NDGA (10-4M) nor quinacrine (10-5 M) had effects on the re laxation response to adenosine (data not shown). adenosine deaminase (13) , and NBTG, an inhibitor of adenosine uptake (14) , on the adenosine-induced relaxation. Hydralazine (3 x 10-7 to 10-5 M) produced a concen tration-dependent augmentation of the relax ation. In contrast, 2'DCF and NBTG at the concentrations tested did not produce significant augmentation. In addition, when 2'DCF (10-5 M) was given in combination with NBTG (10-5 M), the adenosine-induced relaxation was not remarkably affected (data not shown).
Hydralazine augmented both of the relax ation responses to adenosine (10-4 M) and 2-chloroadenosine (3 x 10-5 M) to the same degree. 2-Chloroadenosine at the concen tration used elicited nearly the same magni tude of relaxation (21.4±1.4%, n=24) as adenosine did (19.9±1.3%, n=29). The augmentation of 2-chloroadenosine-induced relaxation with 3x10-7' 10-6, 3 x 10-6 and 10-5 M hydralazine was determined to be 1.22±0.06, 1.68±0.11, 2.12±0.10 and 2.99± 0.24 (n=6), respectively.
Effects of hydralazine, 2'DCF and N BTG on [3H] adenosine uptake by the aortic strips: Hydralazine even at concentrations sufficient to augment the adenosine-induced relaxation did not produce any effect on the tissue level of [3H] compound, whereas the level was significantly (P<0.05 and P< 0.005) decreased by pretreatment with N BTG at concentrations of 3 x 10-6 to 3x`10-5 M. In contrast, the tissue level of [3H] com pound was increased by 2'DCF (Fig. 3) .
Effects of hydralazine on the cyclic nucleotide levels: Results are shown in Table  1 . Hydralazine (10-6, 3 x 10-6 and 10-5 M), per se, did not produce any changes in cyclic AMP and cyclic GMP levels and tension in the aortic strips preconstricted with 10-6 M NE. When 10-4 M adenosine was added, relaxation was elicited with con comitant increase in cyclic AMP (P<0.05), but with no significant change in cyclic GMP. The cyclic AMP increasing effect of ad enosine was slightly but significantly (P< 0.005) augmented in the presence of hy dralazine at concentrations of 3 x 10-6 and 10-5 M, which were sufficient to augment the adenosine-induced relaxation. Although the cyclic GMP level was not significantly changed by adenosine alone, the level was slightly but significantly (P<0.05) increased by adenosine in combination with hy dralazine. (17), failed to modify the adenosine-induced relaxation rule out the possible involvement of local generation of the endogenous metabolites of arachidonic acid in the relaxation to ad enosine.
Huang and Daly (14) reported that S (P-nitrobenzyl) -6-thioguanosine (NBTG) and other inhibitors of adenosine transport into brain slices increased the cyclic AMP response to adenosine. These authors sug gested that these agents increased the effective concentration of adenosine at ex tracellular sites. On the other hand, the adenosine-induced relaxation remained unaf fected in the presence of NBTG which significantly inhibited the transport of [3H] adenosine into aortic smooth muscle. The difference between effects of NBTG in aortic preparations and brain slices may be ex plained by the absence of a diffusion barrier limiting access of adenosine to the cell membrane in the former (18).
The use of an inhibitor of adenosine deaminase often appears to cause a signifi cant accumulation of adenosine to trigger biological responses (19 had no effect on the ad enosine-induced relaxation. In addition, when 2'DCF was given in combination with NBTG, the adenosine-induced relaxation was not remarkably affected. Thus, augmentation of the adenosine-induced relaxation with hy dralazine probably did not result from an inhibition of adenosine transport and/or adenosine deaminase with the agent. This speculation seems to be supported in part by the findings that hydralazine also augments the relaxation response to 2-chloroadenosine, which is not a substrate for uptake (20) and adenosine deaminase (21).
With respect to the cyclic nucleotide metabolism, no effects of hydralazine alone were observed on cyclic AMP and cyclic GMP levels at a concentration of 10-5 M or less. On the other hand, many studies have shown adenosine-elicited increases in intra cellular cyclic AMP levels in vascular smooth muscle strips and cultured vascular smooth muscle cells (22). It is also well established that agents which stimulate the guanylate cyclase and consequently elevate the level of cyclic GMP are capable of relaxing the vascular smooth muscle (23, 24) . In the present experiments, when adenosine was added to the preconstricted aortic strips, relaxation was elicited with concomitant in crease in cyclic AMP, but with no significant change in cyclic GMP level. The cyclic AMP increasing effect of adenosine was slightly but significantly augmented in the presence of hydralazine. The cyclic GMP level was slightly but significantly increased by ad enosine in combination with hydralazine. These changes in cyclic nucletide levels may at least partly relate to the augmentation of adenosine-induced relaxation with hydral azine.
After concluding the present experiments, a report by Kurtz (25) was published. He demostrated that low concentrations of ad enosine alone increased cyclic GMP levels in isolated vascular smooth muscle cells from rat aorta and suggested that adenosine exerted relaxing effects by stimulating guanylate cyclase. These findings are con sistent in part with the present results, although experimental conditions are dif ferent in detail.
